Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
April 15, 2024 13:39 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 15 April 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S - share repurchase programme
April 15, 2024 08:43 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 15 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S - share repurchase programme
April 08, 2024 09:40 ET
|
Novo Nordisk A/S
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 08 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No...
Novo Nordisk A/S - share repurchase programme
April 02, 2024 06:56 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 2 April 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk A/S - share repurchase programme
March 25, 2024 07:58 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 25 March 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
March 25, 2024 05:59 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, and Hannover, Germany, 25 March, 2024 – Novo Nordisk and Cardior Pharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros,...
Vedtægter for Novo Nordisk A/S 2024
March 25, 2024 03:51 ET
|
Novo Nordisk A/S
Vedtægter for Novo Nordisk A/S 2024
Vedhæftet fil
Vedtægter 21 Mar 2024
...
Novo Nordisk A/S - Articles of Association 2024
March 25, 2024 03:51 ET
|
Novo Nordisk A/S
Novo Nordisk's Articles of Association 2024
Attachment
Articles of Association 21 Mar 2024
...
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
March 21, 2024 11:55 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 21 March 2024 – Novo Nordisk today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending...
Resolutions from the Annual General Meeting of Novo Nordisk A/S
March 21, 2024 10:59 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 21 March 2024 - Today, Novo Nordisk A/S held its Annual General Meeting. At the Annual General Meeting, Helge Lund, chair of the Board of Directors communicated: “We are very...